 CINCINNATI, April 11, 2022 GLOBE NEWSWIRE -- Blue Water Vaccines Inc. BWV or Blue Water Vaccines or the Company a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Brian Price, Ph.D., Head of Technology Strategy, will deliver a presentation during the World Vaccine Congress 2022 in Washington, DC. BWV will present on its universal influenza vaccine candidate, which utilizes the exclusively licensed epitopes of limited variability identified by scientists at The University of Oxford. 